United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility
United Therapeutics opened its third Designated Pathogen-Free xenograft production facility, in Houston, Texas, named for transplantation pioneers Dr. Bartley Griffith and Dr. Robert Montgomery. The biosecure facility is purpose-built to manufacture the company's xenokidneys and xenohearts, joining facilities in Virginia and Minnesota that are designed to enable commercial-scale production following potential FDA approval.
Key figures
- Drug Name
- UKidney, UThymoKidney, UHeart
- Clinical trials
- ["EXPAND (UKidney)","EXTEND (UThymoKidney)","EXPRESS (UHeart)"]
- Dpf facilities open
- 3
- Gene edits ukidney uheart
- 10
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.